Evidence map›Paper›PMID 28864699›Full record

Trial reportBMJ open2017

Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali.

Alexandre Dumont, Cécile Bodin, Benjamin Hounkpatin, Thomas Popowski, Mamadou Traoré, René Perrin, Patrick Rozenberg

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Cost-effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2020
    Pooled it
  3. Pooled it
  4. Trial
  5. Suction tube uterine tamponade versus uterine balloon tamponade for treatment of refractory postpartum hemorrhage: A randomized clinical feasibility trial.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Trial
  6. Trial
  7. Trial
  8. Achieving Equitable Access to Obstetric Devices Through Innovation, Improvisation and Off-Label Use.BJOG : an international journal of obstetrics and gynaecology · 2025
    Review
  9. Article
  10. Article
  11. Bakri Balloon for Treatment of Postpartum Hemorrhage: A Real-World 2016-2020 Study in 279 Women from a Single Center.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  12. Observational
  13. Article
  14. Review
  15. FIGO recommendations on the management of postpartum hemorrhage 2022.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2022
    Article
  16. A case series of post-partum haemorrhage managed using Ellavi uterine balloon tamponade in a rural regional hospital.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2021
    Article
  17. Postpartum hemorrhage care bundles to improve adherence to guidelines: A WHO technical consultation.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2020
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Alexandre DumontResearch Institute for Development, Université Paris Descartes, Paris, France.
Cécile BodinResearch Institute for Development, Université Paris Descartes, Paris, France.
Benjamin HounkpatinDepartment of Obstetrics and Gynaecology, CHU-MEL, University Hospital for Mother and Child of Lagune, Cotonou, Benin.
Thomas PopowskiDepartment of Obstetrics and Gynaecology, Poissy Saint Germain Hospital, Poissy, France.
Mamadou TraoréDepartment of Obstetrics and Gynaecology, Referral Health Center of the Commune V, Bamako, Mali.
René PerrinDepartment of Obstetrics and Gynaecology, CHU-MEL, University Hospital for Mother and Child of Lagune, Cotonou, Benin.
Patrick RozenbergDepartment of Obstetric and Gynecology, Poissy Saint Germain Hospital, Poissy, France.
Centre Hospitalier Intercommunal de Poissy · FRDélégation Paris 5 · FRMali-Folkecenter · MLUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the effectiveness of low-cost uterine tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage (PPH) in low-resource settings.

designRandomised controlled trial.

settingSeven healthcare facilities in Cotonou, Benin and Bamako, Mali. POPULATION: Women delivering vaginally who had clinically diagnosed PPH that was suspected to be due to uterine atony, who were unresponsive to oxytocin and who needed additional uterotonics.

methodsWomen were randomly assigned to receive uterine balloon tamponade with a condom-catheter device or no tamponade; both groups were also given intrarectal or sublingual misoprostol.

main outcome measureProportion of women with invasive surgery or who died before hospital discharge.

resultsThe proportion of primary composite outcome did not differ significantly between the tamponade arm (16%; 9/57) and the standard second line treatment arm (7%; 4/59): relative risk 2.33 (95% CI 0.76 to 7.14, p=0.238). A significantly increased proportion of women with tamponade and misoprostol versus misoprostol alone had total blood loss more than 1000 mL: relative risk 1.52 (95% CI 1.15 to 2.00, p=0.01). Case fatality rate was higher in the tamponade group (10%; 6/57) than in the control group (2%; 1/59) (p=0.059). TRIAL REGISTRATION NUMBER: ISRCT Registry Number 01202389; Post-results.

Indexed as

AdultBeninCathetersCombined Modality TherapyCondomsFemaleHumansMaliMisoprostolOxytocicsPostpartum HemorrhagePregnancyUterine Balloon TamponadeYoung AdultMisoprostolOxytocicslow resource settingsmisoprostolpost-partum haemorrhagerandomized controlled trialsecond line therapyuterine balloon tamponade

Identifiers

PMID28864699
PMCPMC5589006
OpenAlexW2751848707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.